CD8A and HIV infectious disease: In the context of HIV infection, Olesen et al (2015) have reported using data from two recent separate clinical trials that the treatment of HIV‐1‐infected patients with panobinostat and romidepsin did not decrease the levels of HIV‐1‐specific effector memory CD8+ T cells.